Review



infinity total cholesterol kit  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    Thermo Fisher infinity total cholesterol kit
    Infinity Total Cholesterol Kit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 8424 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/infinity total cholesterol kit/product/Thermo Fisher
    Average 99 stars, based on 8424 article reviews
    infinity total cholesterol kit - by Bioz Stars, 2026-03
    99/100 stars

    Images



    Similar Products

    infinity total cholesterol kit  (Thermo Fisher)
    99
    Thermo Fisher infinity total cholesterol kit
    Infinity Total Cholesterol Kit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/infinity total cholesterol kit/product/Thermo Fisher
    Average 99 stars, based on 1 article reviews
    infinity total cholesterol kit - by Bioz Stars, 2026-03
    99/100 stars
    		  Buy from Supplier
    total cholesterol infinity cholesterol kit  (Thermo Fisher)
    90
    Thermo Fisher total cholesterol infinity cholesterol kit
    Metabolic parameters of tamoxifen-treated endothelial-cell-specific IR-deficient (IR f/f -Cdh5-Cre (+)) and control (IR f/f -Cdh5-Cre (−)) mice. LFD: Low-fat diet; HFSD: High-fat, high-sucrose diet. Data are expressed as mean ± SEM. Parametric or non-parametric tests were applied according to the results of normality tests. Three-way ANOVA followed by Tukey’s test: significant diet main effect was found for body weight, fasting plasma glucose, fed plasma glucose, IGF-1, triglycerides, free fatty acids, and total <t> cholesterol </t> (* p < 0.05); significant treatment main effect was found for insulin, triglycerides, and free fatty acids ( $ p < 0.001). n > 6 for each group.
    Total Cholesterol Infinity Cholesterol Kit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/total cholesterol infinity cholesterol kit/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    total cholesterol infinity cholesterol kit - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    infinity total cholesterol assay kit  (Fisher Scientific)
    90
    Fisher Scientific infinity total cholesterol assay kit
    Metabolic parameters of tamoxifen-treated endothelial-cell-specific IR-deficient (IR f/f -Cdh5-Cre (+)) and control (IR f/f -Cdh5-Cre (−)) mice. LFD: Low-fat diet; HFSD: High-fat, high-sucrose diet. Data are expressed as mean ± SEM. Parametric or non-parametric tests were applied according to the results of normality tests. Three-way ANOVA followed by Tukey’s test: significant diet main effect was found for body weight, fasting plasma glucose, fed plasma glucose, IGF-1, triglycerides, free fatty acids, and total <t> cholesterol </t> (* p < 0.05); significant treatment main effect was found for insulin, triglycerides, and free fatty acids ( $ p < 0.001). n > 6 for each group.
    Infinity Total Cholesterol Assay Kit, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/infinity total cholesterol assay kit/product/Fisher Scientific
    Average 90 stars, based on 1 article reviews
    infinity total cholesterol assay kit - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Metabolic parameters of tamoxifen-treated endothelial-cell-specific IR-deficient (IR f/f -Cdh5-Cre (+)) and control (IR f/f -Cdh5-Cre (−)) mice. LFD: Low-fat diet; HFSD: High-fat, high-sucrose diet. Data are expressed as mean ± SEM. Parametric or non-parametric tests were applied according to the results of normality tests. Three-way ANOVA followed by Tukey’s test: significant diet main effect was found for body weight, fasting plasma glucose, fed plasma glucose, IGF-1, triglycerides, free fatty acids, and total cholesterol (* p < 0.05); significant treatment main effect was found for insulin, triglycerides, and free fatty acids ( $ p < 0.001). n > 6 for each group.

    Journal: Cells

    Article Title: Cell-Specific Effects of Insulin in a Murine Model of Restenosis Under Insulin-Sensitive and Insulin-Resistant Conditions

    doi: 10.3390/cells13161387

    Figure Lengend Snippet: Metabolic parameters of tamoxifen-treated endothelial-cell-specific IR-deficient (IR f/f -Cdh5-Cre (+)) and control (IR f/f -Cdh5-Cre (−)) mice. LFD: Low-fat diet; HFSD: High-fat, high-sucrose diet. Data are expressed as mean ± SEM. Parametric or non-parametric tests were applied according to the results of normality tests. Three-way ANOVA followed by Tukey’s test: significant diet main effect was found for body weight, fasting plasma glucose, fed plasma glucose, IGF-1, triglycerides, free fatty acids, and total cholesterol (* p < 0.05); significant treatment main effect was found for insulin, triglycerides, and free fatty acids ( $ p < 0.001). n > 6 for each group.

    Article Snippet: In addition, blood samples were collected via cardiac puncture at the time of sacrifice for analysis of metabolic parameters, such as plasma insulin (ELISA obtained from ALPCO, Salem, NH, USA, Catalog #80-INSMS-E01, E10), insulin-like growth factor 1 (IGF-1) (ELISA obtained from R&D systems, Minneapolis, MN, USA, Catalog #MG100), vascular endothelial growth factor (VEGF) (ELISA obtained from R&D systems, Minneapolis, MN, USA, Catalog #MMV00-1), triglyceride (TG), free fatty acids (FFAs) (both colorimetric assay technique, Wako Diagnostics, Osaka, Japan), and total cholesterol (Infinity Cholesterol Kit obtained from Thermo Scientific, Waltham, MA, USA, Catalog #TR13421).

    Techniques: Control, Clinical Proteomics

    Metabolic parameters of tamoxifen-treated smooth-muscle-cell-specific IR-deficient (IR f/f -SMMHC-Cre (+)) and control (IR f/f -SMMHC-Cre (−)) mice. LFD: Low-fat diet; HFSD: High-fat, high-sucrose diet. Data are expressed as mean ± SEM. Parametric or non-parametric tests were applied according to the results of normality tests. Three-way ANOVA followed by Tukey’s test: significant diet main effect was found for body weight, fasting plasma glucose, fed plasma glucose, IGF-1, triglycerides, free fatty acids, and total cholesterol (* p < 0.05); significant treatment main effect was found for insulin, triglycerides, and free fatty acids ( $ p < 0.05). n > 6 for each group.

    Journal: Cells

    Article Title: Cell-Specific Effects of Insulin in a Murine Model of Restenosis Under Insulin-Sensitive and Insulin-Resistant Conditions

    doi: 10.3390/cells13161387

    Figure Lengend Snippet: Metabolic parameters of tamoxifen-treated smooth-muscle-cell-specific IR-deficient (IR f/f -SMMHC-Cre (+)) and control (IR f/f -SMMHC-Cre (−)) mice. LFD: Low-fat diet; HFSD: High-fat, high-sucrose diet. Data are expressed as mean ± SEM. Parametric or non-parametric tests were applied according to the results of normality tests. Three-way ANOVA followed by Tukey’s test: significant diet main effect was found for body weight, fasting plasma glucose, fed plasma glucose, IGF-1, triglycerides, free fatty acids, and total cholesterol (* p < 0.05); significant treatment main effect was found for insulin, triglycerides, and free fatty acids ( $ p < 0.05). n > 6 for each group.

    Article Snippet: In addition, blood samples were collected via cardiac puncture at the time of sacrifice for analysis of metabolic parameters, such as plasma insulin (ELISA obtained from ALPCO, Salem, NH, USA, Catalog #80-INSMS-E01, E10), insulin-like growth factor 1 (IGF-1) (ELISA obtained from R&D systems, Minneapolis, MN, USA, Catalog #MG100), vascular endothelial growth factor (VEGF) (ELISA obtained from R&D systems, Minneapolis, MN, USA, Catalog #MMV00-1), triglyceride (TG), free fatty acids (FFAs) (both colorimetric assay technique, Wako Diagnostics, Osaka, Japan), and total cholesterol (Infinity Cholesterol Kit obtained from Thermo Scientific, Waltham, MA, USA, Catalog #TR13421).

    Techniques: Control, Clinical Proteomics